APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Syringes

Insulin syringes are small-capacity syringe systems with graduations configured for a specified insulin concentration and commonly an integrated fine needle.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Unit graduations are tied to the specified concentration; they are not universal volume labels. Device comparison must retain that concentration and graduation relationship.

What turns activity into demand

Device demand is defined by container or delivery function, connection, materials and validated manufacturing. Prefilling adds formulation compatibility and storage integrity to the device boundary.

The commercial boundary

Injection, enteral, oral and analytical devices have different interfaces and intended uses. Representative images establish neither sterility nor clinical suitability.

Which concentration does the graduation scale assume?

Unit graduations are tied to the specified concentration; they are not universal volume labels. Device comparison must retain that concentration and graduation relationship.

Technical reading

Selected research

Industry Growth & Trends

Global Insulin Syringes Industry Growth and Trends Forecast to 2032

22 December 2025117 pages

Choose your research edition.

Industry ResearchInsulin Syringes Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Syringes Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Insulin Syringes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Syringes Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Syringes Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Insulin Syringes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Syringes include Sanofi, Novo Nordisk, Eli Lilly and Company, Ypsomed AG, Wockhardt Ltd, Terumo Corporation, Nipro Medical Corporation, Medtronic Plc and Medline Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Insulin Syringes market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insulin Syringes market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insulin Syringes market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insulin Syringes.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insulin Syringes market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insulin Syringes Market by Company

Sanofi

Novo Nordisk

Eli Lilly and Company

Ypsomed AG

Wockhardt Ltd

Terumo Corporation

Nipro Medical Corporation

Medtronic Plc

Medline Industries

HMD Healthcare Ltd

F. Hoffmann-La Roche

Cardinal Health Inc

Braun Melunsun

Biocon Ltd

BD

Animas Corporation

Abbott Laboratories

Insulin Syringes Segment by Type

1/2 CC Syringe

1 CC Syringe

3/10 CC Syringe

Others

Insulin Syringes Segment by Application

Hospital

Homecare

Others

Insulin Syringes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Syringes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Syringes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Syringes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Syringes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insulin Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1/2 CC Syringe Table 2. Major Company of 1 CC Syringe Table 3. Major Company of 3/10 CC Syringe Table 4. Major Company of Others Table 5. Global Insulin Syringes Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Insulin Syringes Sales by Type (2021-2026) & (k units) Table 7. Global Insulin Syringes Sales Market Share in Volume by Type (2021-2026) Table 8. Global Insulin Syringes Sales by Type (2021-2026) & (US$ Million) Table 9. Global Insulin Syringes Sales Market Share in Value by Type (2021-2026) Table 10. Global Insulin Syringes Price by Type (2021-2026) & (US$/unit) Table 11. Global Insulin Syringes Sales by Type (2027-2032) & (k units) Table 12. Global Insulin Syringes Sales Market Share in Volume by Type (2027-2032) Table 13. Global Insulin Syringes Sales by Type (2027-2032) & (US$ Million) Table 14. Global Insulin Syringes Sales Market Share in Value by Type (2027-2032) Table 15. Global Insulin Syringes Price by Type (2027-2032) & (US$/unit) Table 16. North America Insulin Syringes Sales by Type (2021-2026) & (k units) Table 17. North America Insulin Syringes Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Insulin Syringes Sales by Type (2021-2026) & (k units) Table 19. Europe Insulin Syringes Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Insulin Syringes Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Insulin Syringes Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Insulin Syringes Sales by Type (2021-2026) & (k units) Table 23. Latin America Insulin Syringes Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Insulin Syringes Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Insulin Syringes Sales by Type (2021-2026) & (US$ Million) Table 26. Insulin Syringes Industry Trends Table 27. Insulin Syringes Industry Drivers Table 28. Insulin Syringes Industry Opportunities and Challenges Table 29. Insulin Syringes Industry Restraints Table 30. Global Insulin Syringes Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Insulin Syringes Revenue Market Share by Company (2021-2026) Table 32. Global Insulin Syringes Sales by Company (2021-2026) & (k units) Table 33. Global Insulin Syringes Sales Share by Company (2021-2026) Table 34. Global Insulin Syringes Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Insulin Syringes Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Insulin Syringes Major Company Production Sites and Headquarters Table 37. Global Insulin Syringes Company, Product Type & Application Table 38. Global Insulin Syringes Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Insulin Syringes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Insulin Syringes Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Insulin Syringes Sales by Region (2021-2026) & (k units) Table 43. Global Insulin Syringes Sales Market Share in Volume by Region (2021-2026) Table 44. Global Insulin Syringes Sales by Region (2021-2026) & (US$ Million) Table 45. Global Insulin Syringes Sales Market Share in Value by Region (2021-2026) Table 46. Global Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Insulin Syringes Sales by Region (2027-2032) & (k units) Table 48. Global Insulin Syringes Sales Market Share in Volume by Region (2027-2032) Table 49. Global Insulin Syringes Sales by Region (2027-2032) & (US$ Million) Table 50. Global Insulin Syringes Sales Market Share in Value by Region (2027-2032) Table 51. Global Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Insulin Syringes Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Insulin Syringes Sales by Application (2021-2026) & (k units) Table 54. Global Insulin Syringes Sales Market Share in Volume by Application (2021-2026) Table 55. Global Insulin Syringes Sales by Application (2021-2026) & (US$ Million) Table 56. Global Insulin Syringes Sales Market Share in Value by Application (2021-2026) Table 57. Global Insulin Syringes Price by Application (2021-2026) & (US$/unit) Table 58. Global Insulin Syringes Sales by Application (2027-2032) & (k units) Table 59. Global Insulin Syringes Sales Market Share in Volume by Application (2027-2032) Table 60. Global Insulin Syringes Sales by Application (2027-2032) & (US$ Million) Table 61. Global Insulin Syringes Sales Market Share in Value by Application (2027-2032) Table 62. Global Insulin Syringes Price by Application (2027-2032) & (US$/unit) Table 63. North America Insulin Syringes Sales by Application (2021-2026) & (k units) Table 64. North America Insulin Syringes Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Insulin Syringes Sales by Application (2021-2026) & (k units) Table 66. Europe Insulin Syringes Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Insulin Syringes Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Insulin Syringes Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Insulin Syringes Sales by Application (2021-2026) & (k units) Table 70. Latin America Insulin Syringes Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Insulin Syringes Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Insulin Syringes Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sanofi Insulin Syringes Product Portfolio Table 77. Sanofi Recent Development Table 78. Novo Nordisk Company Information Table 79. Novo Nordisk Business Overview Table 80. Novo Nordisk Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Novo Nordisk Insulin Syringes Product Portfolio Table 82. Novo Nordisk Recent Development Table 83. Eli Lilly and Company Company Information Table 84. Eli Lilly and Company Business Overview Table 85. Eli Lilly and Company Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Eli Lilly and Company Insulin Syringes Product Portfolio Table 87. Eli Lilly and Company Recent Development Table 88. Ypsomed AG Company Information Table 89. Ypsomed AG Business Overview Table 90. Ypsomed AG Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Ypsomed AG Insulin Syringes Product Portfolio Table 92. Ypsomed AG Recent Development Table 93. Wockhardt Ltd Company Information Table 94. Wockhardt Ltd Business Overview Table 95. Wockhardt Ltd Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Wockhardt Ltd Insulin Syringes Product Portfolio Table 97. Wockhardt Ltd Recent Development Table 98. Terumo Corporation Company Information Table 99. Terumo Corporation Business Overview Table 100. Terumo Corporation Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Terumo Corporation Insulin Syringes Product Portfolio Table 102. Terumo Corporation Recent Development Table 103. Nipro Medical Corporation Company Information Table 104. Nipro Medical Corporation Business Overview Table 105. Nipro Medical Corporation Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Nipro Medical Corporation Insulin Syringes Product Portfolio Table 107. Nipro Medical Corporation Recent Development Table 108. Medtronic Plc Company Information Table 109. Medtronic Plc Business Overview Table 110. Medtronic Plc Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Medtronic Plc Insulin Syringes Product Portfolio Table 112. Medtronic Plc Recent Development Table 113. Medline Industries Company Information Table 114. Medline Industries Business Overview Table 115. Medline Industries Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Medline Industries Insulin Syringes Product Portfolio Table 117. Medline Industries Recent Development Table 118. HMD Healthcare Ltd Company Information Table 119. HMD Healthcare Ltd Business Overview Table 120. HMD Healthcare Ltd Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. HMD Healthcare Ltd Insulin Syringes Product Portfolio Table 122. HMD Healthcare Ltd Recent Development Table 123. F. Hoffmann-La Roche Company Information Table 124. F. Hoffmann-La Roche Business Overview Table 125. F. Hoffmann-La Roche Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. F. Hoffmann-La Roche Insulin Syringes Product Portfolio Table 127. F. Hoffmann-La Roche Recent Development Table 128. Cardinal Health Inc Company Information Table 129. Cardinal Health Inc Business Overview Table 130. Cardinal Health Inc Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Cardinal Health Inc Insulin Syringes Product Portfolio Table 132. Cardinal Health Inc Recent Development Table 133. Braun Melunsun Company Information Table 134. Braun Melunsun Business Overview Table 135. Braun Melunsun Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Braun Melunsun Insulin Syringes Product Portfolio Table 137. Braun Melunsun Recent Development Table 138. Biocon Ltd Company Information Table 139. Biocon Ltd Business Overview Table 140. Biocon Ltd Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Biocon Ltd Insulin Syringes Product Portfolio Table 142. Biocon Ltd Recent Development Table 143. BD Company Information Table 144. BD Business Overview Table 145. BD Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. BD Insulin Syringes Product Portfolio Table 147. BD Recent Development Table 148. Animas Corporation Company Information Table 149. Animas Corporation Business Overview Table 150. Animas Corporation Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Animas Corporation Insulin Syringes Product Portfolio Table 152. Animas Corporation Recent Development Table 153. Abbott Laboratories Company Information Table 154. Abbott Laboratories Business Overview Table 155. Abbott Laboratories Insulin Syringes Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. Abbott Laboratories Insulin Syringes Product Portfolio Table 157. Abbott Laboratories Recent Development Table 158. North America Insulin Syringes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. North America Insulin Syringes Sales by Country (2021-2026) & (k units) Table 160. North America Insulin Syringes Sales Market Share by Country (2021-2026) Table 161. North America Insulin Syringes Sales Forecast by Country (2027-2032) & (k units) Table 162. North America Insulin Syringes Sales Market Share Forecast by Country (2027-2032) Table 163. North America Insulin Syringes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Insulin Syringes Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Insulin Syringes Market Share by Country (2021-2026) Table 166. North America Insulin Syringes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Insulin Syringes Market Share Forecast by Country (2027-2032) Table 168. Europe Insulin Syringes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 169. Europe Insulin Syringes Sales by Country (2021-2026) & (k units) Table 170. Europe Insulin Syringes Sales Market Share by Country (2021-2026) Table 171. Europe Insulin Syringes Sales Forecast by Country (2027-2032) & (k units) Table 172. Europe Insulin Syringes Sales Market Share Forecast by Country (2027-2032) Table 173. Europe Insulin Syringes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Europe Insulin Syringes Market Size by Country (2021-2026) & (US$ Million) Table 175. Europe Insulin Syringes Market Share by Country (2021-2026) Table 176. Europe Insulin Syringes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Europe Insulin Syringes Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Insulin Syringes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Insulin Syringes Sales by Country (2021-2026) & (k units) Table 180. Asia-Pacific Insulin Syringes Sales Market Share by Country (2021-2026) Table 181. Asia-Pacific Insulin Syringes Sales Forecast by Country (2027-2032) & (k units) Table 182. Asia-Pacific Insulin Syringes Sales Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Insulin Syringes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Insulin Syringes Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Insulin Syringes Market Share by Country (2021-2026) Table 186. Asia-Pacific Insulin Syringes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Insulin Syringes Market Share Forecast by Country (2027-2032) Table 188. Latin America Insulin Syringes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 189. Latin America Insulin Syringes Sales by Country (2021-2026) & (k units) Table 190. Latin America Insulin Syringes Sales Market Share by Country (2021-2026) Table 191. Latin America Insulin Syringes Sales Forecast by Country (2027-2032) & (k units) Table 192. Latin America Insulin Syringes Sales Market Share Forecast by Country (2027-2032) Table 193. Latin America Insulin Syringes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Latin America Insulin Syringes Market Size by Country (2021-2026) & (US$ Million) Table 195. Latin America Insulin Syringes Market Share by Country (2021-2026) Table 196. Latin America Insulin Syringes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Latin America Insulin Syringes Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Insulin Syringes Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Insulin Syringes Sales by Country (2021-2026) & (k units) Table 200. Middle East and Africa Insulin Syringes Sales Market Share by Country (2021-2026) Table 201. Middle East and Africa Insulin Syringes Sales Forecast by Country (2027-2032) & (k units) Table 202. Middle East and Africa Insulin Syringes Sales Market Share Forecast by Country (2027-2032) Table 203. Middle East and Africa Insulin Syringes Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Middle East and Africa Insulin Syringes Market Size by Country (2021-2026) & (US$ Million) Table 205. Middle East and Africa Insulin Syringes Market Share by Country (2021-2026) Table 206. Middle East and Africa Insulin Syringes Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Middle East and Africa Insulin Syringes Market Share Forecast by Country (2027-2032) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Insulin Syringes Distributors List Table 211. Insulin Syringes Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Insulin Syringes Image Figure 2. Global Insulin Syringes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Syringes Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Syringes Sales (2021-2032) & (k units) Figure 5. 1/2 CC Syringe Image Figure 6. Global 1/2 CC Syringe Sales YoY Growth (2021-2032) & (k units) Figure 7. 1 CC Syringe Image Figure 8. Global 1 CC Syringe Sales YoY Growth (2021-2032) & (k units) Figure 9. 3/10 CC Syringe Image Figure 10. Global 3/10 CC Syringe Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Insulin Syringes Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Insulin Syringes Market Share by Type 2025 VS 2032 Figure 15. North America Insulin Syringes Sales Market Share in Volume by Type in 2025 Figure 16. North America Insulin Syringes Sales Market Share in Value by Type in 2025 Figure 17. Europe Insulin Syringes Sales Market Share in Volume by Type in 2025 Figure 18. Europe Insulin Syringes Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Insulin Syringes Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Insulin Syringes Sales Market Share in Value by Type in 2025 Figure 21. Latin America Insulin Syringes Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Insulin Syringes Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Insulin Syringes Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Insulin Syringes Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Insulin Syringes Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Homecare Image Figure 30. Global Homecare Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Insulin Syringes Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Insulin Syringes Market Share by Application 2025 VS 2032 Figure 35. North America Insulin Syringes Sales Market Share in Volume by Application in 2025 Figure 36. North America Insulin Syringes Sales Market Share in Value by Application in 2025 Figure 37. Europe Insulin Syringes Sales Market Share in Volume by Application in 2025 Figure 38. Europe Insulin Syringes Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Insulin Syringes Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Insulin Syringes Sales Market Share in Value by Application in 2025 Figure 41. Latin America Insulin Syringes Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Insulin Syringes Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Insulin Syringes Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Insulin Syringes Sales Market Share in Value by Application in 2025 Figure 45. North America Insulin Syringes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Insulin Syringes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Insulin Syringes Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Insulin Syringes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Insulin Syringes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Insulin Syringes Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Insulin Syringes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Insulin Syringes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Insulin Syringes Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Insulin Syringes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Insulin Syringes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Insulin Syringes Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Insulin Syringes Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Insulin Syringes Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Insulin Syringes Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Insulin Syringes Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Insulin Syringes Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 1/2 CC Syringe
  • 1 CC Syringe
  • 3/10 CC Syringe
  • Others
Applications
  • Hospital
  • Homecare
  • Others
Companies covered
  • Sanofi
  • Novo Nordisk
  • Eli Lilly and Company
  • Ypsomed AG
  • Wockhardt Ltd
  • Terumo Corporation
  • Nipro Medical Corporation
  • Medtronic Plc
  • Medline Industries
  • HMD Healthcare Ltd
  • F. Hoffmann-La Roche
  • Cardinal Health Inc
  • Braun Melunsun
  • Biocon Ltd
  • BD
  • Animas Corporation
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Syringes Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insulin Syringes Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insulin Syringes Market by Type
  6. 1.3.1 1/2 CC Syringe
  7. 1.3.2 1 CC Syringe
  8. 1.3.3 3/10 CC Syringe
  9. 1.3.4 Others
  10. 1.4 Global Insulin Syringes Market Size by Type
  11. 1.4.1 Global Insulin Syringes Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Insulin Syringes Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Insulin Syringes Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Insulin Syringes Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Insulin Syringes Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Insulin Syringes Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Insulin Syringes Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Insulin Syringes Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insulin Syringes Industry Trends
  2. 2.2 Insulin Syringes Industry Drivers
  3. 2.3 Insulin Syringes Industry Opportunities and Challenges
  4. 2.4 Insulin Syringes Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insulin Syringes Revenue (2021-2026)
  2. 3.2 Global Top Players by Insulin Syringes Sales (2021-2026)
  3. 3.3 Global Top Players by Insulin Syringes Price (2021-2026)
  4. 3.4 Global Insulin Syringes Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Syringes Major Company Production Sites & Headquarters
  6. 3.6 Global Insulin Syringes Company, Product Type & Application
  7. 3.7 Global Insulin Syringes Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Syringes Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Syringes Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Syringes Tier 1, Tier 2, and Tier 3
4 Insulin Syringes Regional Status and Outlook
  1. 4.1 Global Insulin Syringes Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insulin Syringes Historic Market Size by Region
  3. 4.2.1 Global Insulin Syringes Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insulin Syringes Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insulin Syringes Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insulin Syringes Forecasted Market Size by Region
  7. 4.3.1 Global Insulin Syringes Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insulin Syringes Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insulin Syringes Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insulin Syringes by Application
  1. 5.1 Insulin Syringes Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Homecare
  4. 5.1.3 Others
  5. 5.2 Global Insulin Syringes Market Size by Application
  6. 5.2.1 Global Insulin Syringes Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Insulin Syringes Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Insulin Syringes Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Insulin Syringes Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Insulin Syringes Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Insulin Syringes Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Insulin Syringes Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Insulin Syringes Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Insulin Syringes Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novo Nordisk Insulin Syringes Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Eli Lilly and Company
  14. 6.3.1 Eli Lilly and Company Company Information
  15. 6.3.2 Eli Lilly and Company Business Overview
  16. 6.3.3 Eli Lilly and Company Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly and Company Insulin Syringes Product Portfolio
  18. 6.3.5 Eli Lilly and Company Recent Developments
  19. 6.4 Ypsomed AG
  20. 6.4.1 Ypsomed AG Company Information
  21. 6.4.2 Ypsomed AG Business Overview
  22. 6.4.3 Ypsomed AG Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ypsomed AG Insulin Syringes Product Portfolio
  24. 6.4.5 Ypsomed AG Recent Developments
  25. 6.5 Wockhardt Ltd
  26. 6.5.1 Wockhardt Ltd Company Information
  27. 6.5.2 Wockhardt Ltd Business Overview
  28. 6.5.3 Wockhardt Ltd Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Wockhardt Ltd Insulin Syringes Product Portfolio
  30. 6.5.5 Wockhardt Ltd Recent Developments
  31. 6.6 Terumo Corporation
  32. 6.6.1 Terumo Corporation Company Information
  33. 6.6.2 Terumo Corporation Business Overview
  34. 6.6.3 Terumo Corporation Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Terumo Corporation Insulin Syringes Product Portfolio
  36. 6.6.5 Terumo Corporation Recent Developments
  37. 6.7 Nipro Medical Corporation
  38. 6.7.1 Nipro Medical Corporation Company Information
  39. 6.7.2 Nipro Medical Corporation Business Overview
  40. 6.7.3 Nipro Medical Corporation Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nipro Medical Corporation Insulin Syringes Product Portfolio
  42. 6.7.5 Nipro Medical Corporation Recent Developments
  43. 6.8 Medtronic Plc
  44. 6.8.1 Medtronic Plc Company Information
  45. 6.8.2 Medtronic Plc Business Overview
  46. 6.8.3 Medtronic Plc Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Medtronic Plc Insulin Syringes Product Portfolio
  48. 6.8.5 Medtronic Plc Recent Developments
  49. 6.9 Medline Industries
  50. 6.9.1 Medline Industries Company Information
  51. 6.9.2 Medline Industries Business Overview
  52. 6.9.3 Medline Industries Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Medline Industries Insulin Syringes Product Portfolio
  54. 6.9.5 Medline Industries Recent Developments
  55. 6.10 HMD Healthcare Ltd
  56. 6.10.1 HMD Healthcare Ltd Company Information
  57. 6.10.2 HMD Healthcare Ltd Business Overview
  58. 6.10.3 HMD Healthcare Ltd Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 HMD Healthcare Ltd Insulin Syringes Product Portfolio
  60. 6.10.5 HMD Healthcare Ltd Recent Developments
  61. 6.11 F. Hoffmann-La Roche
  62. 6.11.1 F. Hoffmann-La Roche Company Information
  63. 6.11.2 F. Hoffmann-La Roche Business Overview
  64. 6.11.3 F. Hoffmann-La Roche Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 F. Hoffmann-La Roche Insulin Syringes Product Portfolio
  66. 6.11.5 F. Hoffmann-La Roche Recent Developments
  67. 6.12 Cardinal Health Inc
  68. 6.12.1 Cardinal Health Inc Company Information
  69. 6.12.2 Cardinal Health Inc Business Overview
  70. 6.12.3 Cardinal Health Inc Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Cardinal Health Inc Insulin Syringes Product Portfolio
  72. 6.12.5 Cardinal Health Inc Recent Developments
  73. 6.13 Braun Melunsun
  74. 6.13.1 Braun Melunsun Company Information
  75. 6.13.2 Braun Melunsun Business Overview
  76. 6.13.3 Braun Melunsun Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Braun Melunsun Insulin Syringes Product Portfolio
  78. 6.13.5 Braun Melunsun Recent Developments
  79. 6.14 Biocon Ltd
  80. 6.14.1 Biocon Ltd Company Information
  81. 6.14.2 Biocon Ltd Business Overview
  82. 6.14.3 Biocon Ltd Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Biocon Ltd Insulin Syringes Product Portfolio
  84. 6.14.5 Biocon Ltd Recent Developments
  85. 6.15 BD
  86. 6.15.1 BD Company Information
  87. 6.15.2 BD Business Overview
  88. 6.15.3 BD Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 BD Insulin Syringes Product Portfolio
  90. 6.15.5 BD Recent Developments
  91. 6.16 Animas Corporation
  92. 6.16.1 Animas Corporation Company Information
  93. 6.16.2 Animas Corporation Business Overview
  94. 6.16.3 Animas Corporation Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Animas Corporation Insulin Syringes Product Portfolio
  96. 6.16.5 Animas Corporation Recent Developments
  97. 6.17 Abbott Laboratories
  98. 6.17.1 Abbott Laboratories Company Information
  99. 6.17.2 Abbott Laboratories Business Overview
  100. 6.17.3 Abbott Laboratories Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Abbott Laboratories Insulin Syringes Product Portfolio
  102. 6.17.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Insulin Syringes Sales by Country
  2. 7.1.1 North America Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insulin Syringes Sales by Country (2021-2026)
  4. 7.1.3 North America Insulin Syringes Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insulin Syringes Market Size by Country
  6. 7.2.1 North America Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insulin Syringes Market Size by Country (2021-2026)
  8. 7.2.3 North America Insulin Syringes Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insulin Syringes Sales by Country
  2. 8.1.1 Europe Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insulin Syringes Sales by Country (2021-2026)
  4. 8.1.3 Europe Insulin Syringes Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insulin Syringes Market Size by Country
  6. 8.2.1 Europe Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insulin Syringes Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insulin Syringes Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insulin Syringes Sales by Country
  2. 9.1.1 Asia-Pacific Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insulin Syringes Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insulin Syringes Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insulin Syringes Market Size by Country
  6. 9.2.1 Asia-Pacific Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insulin Syringes Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insulin Syringes Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insulin Syringes Sales by Country
  2. 10.1.1 South America Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insulin Syringes Sales by Country (2021-2026)
  4. 10.1.3 South America Insulin Syringes Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insulin Syringes Market Size by Country
  6. 10.2.1 South America Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insulin Syringes Market Size by Country (2021-2026)
  8. 10.2.3 South America Insulin Syringes Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insulin Syringes Sales by Country
  2. 11.1.1 Middle East and Africa Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insulin Syringes Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insulin Syringes Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insulin Syringes Market Size by Country
  6. 11.2.1 Middle East and Africa Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insulin Syringes Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insulin Syringes Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insulin Syringes Value Chain Analysis
  2. 12.1.1 Insulin Syringes Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insulin Syringes Production Mode & Process
  7. 12.2 Insulin Syringes Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insulin Syringes Distributors
  10. 12.2.3 Insulin Syringes Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst